Notable Total Current Liabilities from 2010 to 2024
| NTBL Stock | 0.40 0.01 2.56% |
Total Current Liabilities | First Reported 2010-12-31 | Previous Quarter 2.7 M | Current Value 3.7 M | Quarterly Volatility 2.7 M |
Check Notable Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Notable Labs' main balance sheet or income statement drivers, such as Depreciation And Amortization of 244.2 K, Interest Expense of 115.6 K or Total Revenue of 333.9 K, as well as many indicators such as Price To Sales Ratio of 12.63, Dividend Yield of 0.0 or PTB Ratio of 0.26. Notable financial statements analysis is a perfect complement when working with Notable Labs Valuation or Volatility modules.
Notable | Total Current Liabilities |
Latest Notable Labs' Total Current Liabilities Growth Pattern
Below is the plot of the Total Current Liabilities of Notable Labs over the last few years. Total Current Liabilities is an item on Notable Labs balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Notable Labs are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. Notable Labs' Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Notable Labs' overall financial position and show how it may be relating to other accounts over time.
| Total Current Liabilities | 10 Years Trend |
|
Total Current Liabilities |
| Timeline |
Notable Total Current Liabilities Regression Statistics
| Arithmetic Mean | 6,995,048 | |
| Geometric Mean | 6,243,577 | |
| Coefficient Of Variation | 38.87 | |
| Mean Deviation | 2,289,796 | |
| Median | 8,666,000 | |
| Standard Deviation | 2,718,973 | |
| Sample Variance | 7.4T | |
| Range | 6.7M | |
| R-Value | (0.78) | |
| Mean Square Error | 3.1T | |
| R-Squared | 0.61 | |
| Significance | 0.0006 | |
| Slope | (472,900) | |
| Total Sum of Squares | 103.5T |
Notable Total Current Liabilities History
About Notable Labs Financial Statements
Notable Labs investors utilize fundamental indicators, such as Total Current Liabilities, to predict how Notable Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Current Liabilities | 2.7 M | 3.7 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in Notable Stock
When determining whether Notable Labs is a strong investment it is important to analyze Notable Labs' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Notable Labs' future performance. For an informed investment choice regarding Notable Stock, refer to the following important reports:Check out the analysis of Notable Labs Correlation against competitors. For more information on how to buy Notable Stock please use our How to buy in Notable Stock guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Notable Labs. If investors know Notable will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Notable Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.09) | Revenue Per Share 0.042 | Return On Assets (1.06) | Return On Equity (4.64) |
The market value of Notable Labs is measured differently than its book value, which is the value of Notable that is recorded on the company's balance sheet. Investors also form their own opinion of Notable Labs' value that differs from its market value or its book value, called intrinsic value, which is Notable Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Notable Labs' market value can be influenced by many factors that don't directly affect Notable Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Notable Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Notable Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Notable Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.